Precision Cardiovascular Therapeutics Market

Gene therapy leads the precision cardiovascular therapeutics market with a 41.0% share in 2026, followed by genomics-guided approaches at 44.0%. Market growth depends on molecular diagnosis, durable treatment strategies, and specialist adoption, while long-term safety monitoring and patient selection remain essential for broader clinical implementation.